- Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
-
Oh J, Oh D, Lee SJ, Kim JO, Kim NK, Chong SY, Huh JY, Baker RI, on behalf of the Korean TTP Registry Investigators
- KMID: 2459388
- Blood Res.
- 2019 Sep;54(3):218-228.
- doi: 10.5045/br.2019.54.3.218
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) involves dysregulation of the complement system, but whether this also occurs in thrombotic thrombocytopenic purpura (TTP) remains unclear. Although these conditions are difficult to... -
- CITED
-
- Close
- SHARE
-
- Close
- Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
-
Keong Liam CC, Tiao JYH, Yap YY, Lee YL, Sathar J, McRae S, Davis A, Curnow J, Bird R, Choi P, Angchaisuksiri P, Tien SL, Mei Lam JC, Oh D, Kim JS, Yoon SS, Wong RSM, Lauren C, Merriman EG, Enjeti A, Smith M, Baker RI
- KMID: 2541063
- Blood Res.
- 2023 Mar;58(1):36-41.
- doi: 10.5045/br.2023.2022133
Background The PLASMIC score is a convenient tool for predicting ADAMTS13 activity of ＜10%. Lactate dehydrogenase (LDH) is widely used as a marker of haemolysis in thrombotic thrombocytopenic purpura (TTP) monitoring, and... -
- CITED
-
- Close
- SHARE
-
- Close
